For World Hepatitis Day 2021, we heard from experts about the evidence that treatment as prevention in prisons works and how it can be rolled out in Australia to have the most effective impact.
Kirby Institute Seminar Series – 27 July 2021
Eliminating hepatitis C in prisons will be a crucial setting if World Health Organization (WHO) elimination targets are to be achieved. For World Hepatitis Day, we’ll hear from experts about the evidence that treatment as prevention in prisons works, and how it can be rolled out in Australia to have the most effective impact. Drawing on findings from the Surveillance and treatment of prisoners with hepatitis C (SToP-C) study, the panel will also discuss the importance of integration with drug dependence management.
The webinar is presented through the ASCEND program grant (Advancing the health or people who use drugs: hepatitis C and drug dependence), a collaboration between UNSW Sydney’s Kirby Institute and National Drug and Alcohol Research Centre (NDARC), funded by the National Health and Medical Research Centre.
0:00 Webinar welcome
1:24 Introducing Dr Behzad Hajarizadeh
2:22 Dr Hajarizadeh on overview and findings from the SToP-C Study
18:08 Introducing Dr Lise Lafferty
18:41 Dr Lafferty on experiences and perceptions of treatment as prevention within prisons
29:05 Introducing Professor Andrew Lloyd
29:32 Prof Lloyd on overview of the SToP-C Implementation Toolkit
44:55 Introducing Professor Adrian Dunlop
45:18 Prof Dunlop on long-acting depot buprenorphine in prison
53:19 Q&A
--
With presentations:
- Dr Behzad Hajarizadeh, Senior Lecturer, Kirby Institute
Hepatitis C treatment-as-prevention in the prison setting: The SToP-C Study
- Dr Lise Lafferty, Research Fellow, Kirby Institute
Perceptions and concerns of hepatitis C reinfection within the prison setting
- Professor Andrew Lloyd, Program Head, Kirby Institute
A guide to scale-up of testing and treatment in prisons: the SToP-C Implementation Toolkit
- Professor Adrian Dunlop, Director, Drug and Alcohol Clinical Services, Hunter New England Local Health District
Understanding NSW long-acting opioids in custody: the UNLOC-T study
Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.
0 Comments